Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2020.04.033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A comprehensive review on advanced trends in treatment technologies for removal of Bisphenol A from aquatic media.
Environ Monit Assess
December 2024
Department of Metallurgical and Material Engineering, Karadeniz Technical University, 61080, Trabzon, Turkey.
Toxic environmental pollutants are considered to be posed a major threat to human and aquatic systems. The fast advancement of the petrochemical and chemical industries has woken up rising worries concerning the pollution of water by contaminants including phenolic Bisphenol A (BPA), an endocrine-disrupting chemical (EDC). The intermediate BPA used in synthesis of certain plastics, polycarbonate polymers, polysulfone, and epoxy resins of various polyesters.
View Article and Find Full Text PDFClearing the path: Unraveling bisphenol a removal and degradation mechanisms for a cleaner future.
J Environ Manage
December 2024
ICAR-Central Inland Fisheries Research Institute, Barrackpore, Kolkata, 700 120, West Bengal, India.
Bisphenol A (BPA) is a prevalent chemical found in a range of consumer goods, which has raised worries about its possible health hazards. Comprehending the breakdown pathways of BPA is essential for evaluating its environmental consequences and addressing associated concerns. This review emphasizes the significance of studying the degradation/removal of BPA, with a specific focus on both natural and artificial routes.
View Article and Find Full Text PDFA qualitative study on the management system for investigator-initiated studies in healthcare institutions in Beijing, China.
Health Res Policy Syst
December 2024
Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, No. 38 Xueyuan Rd., Haidian District, Beijing, 100191, China.
Background: The Measures for Management of Investigator-Initiated Studies (IISs) Conducted by Healthcare Institutions (trial version) (referred to as Management Measures) has been piloted successively in 12 provincial regions across China since 1 October 2021 and took effect nationwide on 1 October 2024. This study aimed to examine the perspectives, attitudes and challenges of administrators and investigators within healthcare institutions in Beijing regarding IIS management to provide further strategic guidance in China.
Methods: This descriptive qualitative study included 13 focus group discussions among 74 participants from 25 healthcare institutions stratified selected in Beijing, including 13 executive-level administrators, 41 functional administrators and 20 investigator representatives.
Evidence-based advancements in breast cancer genetic counseling: a review.
Breast Cancer
December 2024
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, A-10, No.17, Tianfu Avenue, Shangliu Distinct, Chengdu, 610002, China.
Purpose: Understanding individuals at high risk of breast cancer, as well as patients and survivors, underscores the critical role of genetic counseling in the diagnosis and treatment of breast cancer.
Methods: This systematic review adhered to the guidelines outlined in the Reporting Items for Systematic Review and Meta-Analysis (PRISMA). The review process was managed using Covidence systematic review software, facilitating data extraction according to predefined eligibility criteria by two independent reviewers.
Nanomaterials for the Diagnosis and Treatment of Triple-Negative Breast Cancer.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
December 2024
State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, People's Republic of China.
In recent years, the diagnosis and treatment at the early stages significantly raise the survival rate of breast cancer patients. Moreover, antibody drugs pave the way toward precision target therapy. However, the treatment and survival of triple-negative breast cancer (TNBC) patients is still worrying, which needs further understanding and study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!